Sunshine Biopharma Inc.
Assets & Liabilities
| Fiscal Year | Total Liabilities | Total Assets | Cash on Hand |
|---|---|---|---|
| FY2021 | $2.0M | $2.2M | $2.0M |
| FY2022 | $7.6M | $29.2M | $21.8M |
| FY2023 | $6.1M | $27.3M | $16.3M |
| FY2024 | $7.1M | $30.6M | $9.7M |
| FY2025 | $7.0M | $30.1M | $9.1M |
Assets & Liabilities
| Fiscal Year | Total Liabilities | Total Assets | Cash on Hand |
|---|---|---|---|
| FY2021 | $2.0M | $2.2M | $2.0M |
| FY2022 | $7.6M | $29.2M | $21.8M |
| FY2023 | $6.1M | $27.3M | $16.3M |
| FY2024 | $7.1M | $30.6M | $9.7M |
| FY2025 | $7.0M | $30.1M | $9.1M |